Close

Canaccord Genuity Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Analyst Day Takeaways Dec 6, 2011 09:10AM
Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Q3/11 Update: Dificid Sales Surpass Expectations Nov 4, 2011 11:28AM
Canaccord Genuity Q3 Biotech Results Preview Oct 25, 2011 11:47AM
Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); DIFICID Uptake Appears Steady Oct 20, 2011 08:42AM
Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); DIFICID Launch Starts Strong Sep 13, 2011 08:33AM


May 31, 2011 09:21AM Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Eyes on Launch Following DIFICID Approval
May 19, 2011 11:09AM Canaccord Genuity Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Model Revisions Ahead of DIFICID Launch
Apr 6, 2011 08:20AM Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Fidaxo Wins FDA Panel Support
Mar 31, 2011 11:08AM Canaccord Genuity Assumes Coverage on Optimer Pharmaceuticals (OPTR) at Buy; FDA Panel Expected to Weigh Favorably on Fidaxo NDA
Feb 3, 2011 11:01AM Canaccord Genuity maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Compelling Clinical Data
Nov 19, 2010 11:02AM Canaccord Genuity maintains a 'Buy' rating on Optimer Pharmaceuticals (OPTR); Mid-2011 Fidaxo Approvals Expected; Robust Launch Prep Underway
Nov 15, 2010 01:37PM Canaccord Genuity Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); 2011 Should Bring US and EU Fidaxo Approvals
Nov 12, 2010 10:19AM Canaccord Genuity Morning Coffee on Optimer (OPTR): A Rash Announcement